BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38115701)

  • 21. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia.
    Tassano E; Acquila M; Tavella E; Micalizzi C; Panarello C; Morerio C
    Genes Chromosomes Cancer; 2010 Aug; 49(8):682-7. PubMed ID: 20544842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification.
    Schwab CJ; Murdy D; Butler E; Enshaei A; Winterman E; Cranston RE; Ryan S; Barretta E; Hawking Z; Murray J; Antony G; Vora A; Moorman AV; Harrison CJ
    Br J Haematol; 2022 Feb; 196(3):753-763. PubMed ID: 34676543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.
    Satake N; Duong C; Chen C; Barisone GA; Diaz E; Tuscano J; Rocke DM; Nolta J; Nitin N
    Br J Haematol; 2014 Nov; 167(4):487-99. PubMed ID: 25196579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of an additional copy of chromosome 21 in B-cell precursor acute lymphoblastic leukemia.
    Hormann FM; Mooij EJ; van de Mheen M; Beverloo HB; den Boer ML; Boer JM
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23217. PubMed ID: 38087879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.
    Huh J; Mun YC; Yoo ES; Seong CM; Chung WS
    Ann Lab Med; 2015 Jan; 35(1):128-31. PubMed ID: 25553293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
    Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
    Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
    Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
    Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
    J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Bakker M; Hoogkamer AQ; Boer JM; Hartman QJ; Stalpers F; Escherich G; de Haas V; de Groot-Kruseman HA; Pieters R; den Boer ML
    Sci Rep; 2018 Jan; 8(1):693. PubMed ID: 29330417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
    Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
    J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
    Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
    Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures.
    Schroeder MP; Bastian L; Eckert C; Gökbuget N; James AR; Tanchez JO; Schlee C; Isaakidis K; Häupl B; Baum K; Migueles Lozano OA; Kouidri K; Pan KT; Urlaub H; Schwartz S; Burmeister T; von Stackelberg A; Hoelzer D; Pfeiffer H; Rieger MA; Göllner S; Oellerich T; Horstman M; Schrappe M; Wolf J; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Neumann M; Baldus CD
    Sci Rep; 2019 Mar; 9(1):4188. PubMed ID: 30862934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia.
    Gawad C; Pepin F; Carlton VE; Klinger M; Logan AC; Miklos DB; Faham M; Dahl G; Lacayo N
    Blood; 2012 Nov; 120(22):4407-17. PubMed ID: 22932801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
    Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
    J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute lymphoblastic leukemia of adolescents and young adults: from the viewpoint of physicians].
    Yasuda T; Hayakawa F
    Rinsho Ketsueki; 2017; 58(8):1031-1037. PubMed ID: 28883266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.
    Steenbergen EJ; Verhagen OJ; Nibbering CP; van den Berg H; van Leeuwen EF; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1996 Sep; 10(9):1471-8. PubMed ID: 8751465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic gatekeeper function of B-lymphoid transcription factors.
    Chan LN; Chen Z; Braas D; Lee JW; Xiao G; Geng H; Cosgun KN; Hurtz C; Shojaee S; Cazzaniga V; Schjerven H; Ernst T; Hochhaus A; Kornblau SM; Konopleva M; Pufall MA; Cazzaniga G; Liu GJ; Milne TA; Koeffler HP; Ross TS; Sánchez-García I; Borkhardt A; Yamamoto KR; Dickins RA; Graeber TG; Müschen M
    Nature; 2017 Feb; 542(7642):479-483. PubMed ID: 28192788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
    Zhang J; McCastlain K; Yoshihara H; Xu B; Chang Y; Churchman ML; Wu G; Li Y; Wei L; Iacobucci I; Liu Y; Qu C; Wen J; Edmonson M; Payne-Turner D; Kaufmann KB; Takayanagi SI; Wienholds E; Waanders E; Ntziachristos P; Bakogianni S; Wang J; Aifantis I; Roberts KG; Ma J; Song G; Easton J; Mulder HL; Chen X; Newman S; Ma X; Rusch M; Gupta P; Boggs K; Vadodaria B; Dalton J; Liu Y; Valentine ML; Ding L; Lu C; Fulton RS; Fulton L; Tabib Y; Ochoa K; Devidas M; Pei D; Cheng C; Yang J; Evans WE; Relling MV; Pui CH; Jeha S; Harvey RC; Chen IL; Willman CL; Marcucci G; Bloomfield CD; Kohlschmidt J; Mrózek K; Paietta E; Tallman MS; Stock W; Foster MC; Racevskis J; Rowe JM; Luger S; Kornblau SM; Shurtleff SA; Raimondi SC; Mardis ER; Wilson RK; Dick JE; Hunger SP; Loh ML; Downing JR; Mullighan CG;
    Nat Genet; 2016 Dec; 48(12):1481-1489. PubMed ID: 27776115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.